FDA Approves First Oral Obesity Drug as Fitness Trends and Nutrition Standards Evolve in Late 2025
Share
Top Developments in Weight Management, Healthy Living, and Healthy Eating: December 21-28, 2025
1. FDA Approval of Oral Semaglutide Pill for Weight Loss
In a significant development, U.S. regulators approved the first daily oral medication for obesity treatment, Novo Nordisk's Wegovy pill (25 mg semaglutide), in late December 2025. Clinical trials demonstrated robust efficacy, with participants losing an average of 13.6% of their body weight over 15 months compared to just 2.2% among the placebo group. This new oral option provides a convenient alternative to injectable GLP-1 medications and is expected to be available to patients within weeks after approval. The estimated starting cost for the pill is approximately $149 per month.
2. Rising Discontinuation Rates of GLP-1 Drugs Among Older Adults
Recent analyses highlight that approximately 60% of Americans aged 65 and older with diabetes discontinue semaglutide within one year. Older patients are between 20-30% more likely than younger counterparts to stop GLP-1 drug therapies, often resulting in weight regain and loss of associated improvements such as lower blood pressure and cholesterol levels. This trend raises concerns about long-term adherence and calls for tailored strategies to improve sustained use and health outcomes in the older population.
3. AI Advances in Predicting Nutrition Risks for ICU Patients
Researchers at Mount Sinai developed an artificial intelligence system dubbed NutriSighT to predict the risk of underfeeding in critically ill patients. The study revealed that 41-53% of ventilated ICU patients were underfed by the third day of intensive care, and 25-35% remained underfed by day seven. By leveraging AI predictions, clinicians can intervene earlier to optimize nutrition support, potentially improving patient recovery and outcomes.
4. Viral 12-3-30 Treadmill Workout Demonstrates Fat-Burning Benefits Compared to Running
A study published in the International Journal of Exercise Science evaluated the popular 12-3-30 treadmill workout (12% incline, 3 mph, 30 minutes). Results showed it burns approximately 40.56% of energy from fat, higher than the 33% fat oxidation rate observed during running. Despite running burning calories at a faster rate (about 13 calories/minute versus 10 calories/minute for 12-3-30), the incline walking significantly shifts energy metabolism to fat utilization, suggesting benefits for targeted fat loss.
5. Updates to School Nutrition Standards Effective July 2025
New nutrition standards in California and at the federal level now impose stricter limits on added sugars and grain quality in school meals. Breakfast cereals are restricted to no more than 6 grams of added sugar per dry ounce, flavored milk must not exceed 10-15 grams of added sugar per 8 fluid ounces, and at least 80% of grains served weekly are required to be whole grain. Additionally, nuts and seeds can now fully credit as meat/meat alternate components. These changes aim to improve childhood nutrition quality and help combat pediatric obesity trends.
Sources
- https://www.latimes.com/science/story/2025-12-25/u-s-regulators-approve-wegovy-pill-for-weight-loss
- https://www.ama-assn.org/about/publications-newsletters/top-news-stories-ama-morning-rounds-week-dec-22-2025
- https://www.mountsinai.org/about/newsroom/2025/ai-could-help-predict-nutrition-risks-in-icu-patients-study-finds
- https://www.foxnews.com/health/viral-treadmill-trend-may-burn-more-fat-than-running-researchers-say
- https://www.cde.ca.gov/ls/nu/sn/mbsnp142025.asp